Published: 2018-12-09

Articles

Do Prior Authorization Policies Discourage First-Line Antipsychotic Use in Patients Newly Discharged from a Hospitalization for Schizophrenia in Saskatchewan?

David F Blackburn, David Tran, Alex Crawley, Sarah Lynds, Anne Champagne, Lauren Bresee
Abstract 76 | PDF Downloads 33

Canada's Progress Toward an Orphan Drug Framework: 2014

Stuart MacLeod
Abstract 121 | PDF Downloads 37

An Orphan Drug Framework (ODF) for Canada

David K Lee, Barbara Wong
Abstract 224 | PDF Downloads 212

Redefining Cancer: A New Paradigm for Better and Faster Treatment Innovation

David J Stewart, Gerald Batist
Abstract 156 | PDF Downloads 58

A New Toolkit for Conducting Clinical Trials in Rare Disorders

Lusine Abrahamyan, Ivan R Diamond, Sindhu R Johnson, Brian M Feldman
Abstract 107 | PDF Downloads 80

A New Toolkit for Conducting Clinical Trials in Rare Disorders: Will This Dog Hunt?

Robert G Peterson, Stuart M MacLeod, Agnes V Klein
Abstract 84 | PDF Downloads 54

The Differential Diagnosis of Fetal Alcohol Spectrum Disorder

Tom Leibson, Gal Neuman, Albert E Chudley, Gideon Koren
Abstract 954 | PDF Downloads 395

Validation of the Photographic Method in Fetal Alcohol Spectrum Disorder Screening and Diagnosis

Marina Avner, Paul Henning, Gideon Koren, Irena Nulman
Abstract 96 | PDF Downloads 145